Usp18 Expression in CD169(+) Macrophages is Important for Strong Immune Response after Vaccination with VSV-EBOV

Friedrich, SK; Schmitz, R; Bergerhausen, M; Lang, J; Cham, LB; Duhan, V; Haussinger, D; Hardt, C; Addo, M; Prinz, M; Asano, K; Lang, PA; Lang, KS

Lang, KS (corresponding author), Univ Duisburg Essen, Inst Immunol, Hufelandstr 55, D-45147 Essen, Germany.

VACCINES, 2020; 8 (1):

Abstract

Ebola virus epidemics can be effectively limited by the VSV-EBOV vaccine (Ervebo) due to its rapid protection abilities; however, side effects prevent......

Full Text Link